Findings of Research Misconduct; Correction, 8202-8203 [2021-02272]

Download as PDF 8202 Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices Dated: February 1, 2021. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2021–02358 Filed 2–3–21; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES FOR FURTHER INFORMATION CONTACT: Centers for Medicare & Medicaid Services William Parham at (410) 786–4669. Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. SUMMARY: Comments on the collection(s) of information must be received by the OMB desk officer by March 8, 2021. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. To obtain copies of a supporting statement and any related forms for the jbell on DSKJLSW7X2PROD with NOTICES VerDate Sep<11>2014 17:13 Feb 03, 2021 Jkt 253001 Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires federal agencies to publish a 30-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice that summarizes the following proposed collection(s) of information for public comment: 1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: State Medicaid HIT Plan, Planning Advance Planning Document, and Implementation Advance Planning Document for Section 4201 of the Recovery Act; Use: To assess the appropriateness of state requests for the administrative Federal financial participation for expenditures under their Medicaid Electronic Health Record Incentive Program related to health information exchange, our staff will review the submitted information and documentation to make an approval determination of the state advance planning document. Form Number: CMS–10292 (OMB control number: 0938–1088); Frequency: Once and occasionally; Affected Public: State, Local, and Tribal Governments; Number of Respondents: 56; Total Annual Responses: 56; Total Annual Hours: 896. (For policy questions regarding this collection contact Edward Dolly at 410– 786–8554.) SUPPLEMENTARY INFORMATION: [Document Identifier: CMS–10292] DATES: proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at website address at https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing.html. 2. Call the Reports Clearance Office at (410) 786–1326. PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Dated: February 1, 2021. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2021–02319 Filed 2–3–21; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct; Correction Office of the Secretary, HHS. Correction of notice. AGENCY: ACTION: This document corrects errors that appeared in the notice published in the November 7, 2019, Federal Register entitled ‘‘Findings of Research Misconduct.’’ SUMMARY: DATES: Effective Date: February 4, 2021. Applicability Date: The correction notice is applicable for the Findings of Research Misconduct notice published on November 7, 2019. FOR FURTHER INFORMATION CONTACT: Ms. Karen Gorirossi or Dr. Alexander Runko at 240–453–8800. SUPPLEMENTARY INFORMATION: I. Background In FR Doc. 2019–24291 of November 7, 2019 (84 FR 60097–60098), there were errors involving incorrect citations for published papers affecting six paragraphs on page 60098. The errors are identified and corrected in the Correction of Errors section below. II. Correction of Errors In FR Doc. 2019–24291 of November 7, 2019 (84 FR 60097–60098), make the following corrections: 1. On page 60098, first column, in FR Doc. 2019–24291, fifth paragraph, lines 1–2, change ‘‘Am. J. Physiol. Lung Cell. Mol. Biol.’’ to ‘‘Am. J. Resp. Cell. Mol. Biol.’’ and in lines 3–5, remove ‘‘(hereafter referred to as ‘‘Am. J. Physiol. Lung Cell. Mol. Biol. 2011b paper).’’ 2. On page 60098, first column, in FR Doc. 2019–24291, twelfth paragraph, lines 1–2, change ‘‘Am. J. Physiol. Lung Cell. Mol. Biol.’’ to ‘‘Am. J. Resp. Cell. Mol. Biol.’’ 3. On page 60098, first column, in FR Doc. 2019–24291, sixteenth paragraph, lines 1–2, change ‘‘J. Immunol. 2007;2179:4367–75’’ to ‘‘J. Immunol. 2007;179:4367–75.’’ 4. On page 60098, second column, in FR Doc. 2019–24291, second paragraph, E:\FR\FM\04FEN1.SGM 04FEN1 Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices lines 2–3, change ‘‘Am. J. Physiol. Lung Cell. Mol. Biol.’’ to ‘‘Am. J. Resp. Cell. Mol. Biol.’’ 5. On page 60098, second column, in FR Doc. 2019–24291, sixth paragraph, lines 1 and 3, change ‘‘J. App. Physiol.’’ to ‘‘J. Appl. Physiol.’’ 6. On page 60098, second column, in FR Doc. 2019–24291, twenty-third paragraph, lines 1–2, change ‘‘Am. J. Physiol. Lung Cell. Mol. Biol. 2011b paper’’ to ‘‘Am. J. Physiol. Lung Cell. Mol. Physiol. 2011;301(3):L327–L333.’’ Dated: January 29, 2021. Wanda K. Jones, Acting Director, Office of Research Integrity. [FR Doc. 2021–02272 Filed 2–3–21; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: Findings of research misconduct have been made against Yibin Lin, Ph.D. (Respondent), former postdoctoral fellow, McGovern Medical School, University of Texas Health Science Center (UTHealth). Respondent engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), grant R01 AI125216. The administrative actions, including debarment for a period of ten (10) years, were implemented beginning on January 7, 2021, and are detailed below. SUMMARY: jbell on DSKJLSW7X2PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Wanda K. Jones, Dr. P.H., Acting Director, Office of Research Integrity, 1101 Wootton Parkway, Suite 240, Rockville, MD 20852, (240) 453–8200. SUPPLEMENTARY INFORMATION: Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following case: Yibin Lin, Ph.D., University of Texas Health Science Center: Based on the report of an assessment conducted by UTHealth, Respondent’s admission, and analysis conducted by ORI in its oversight review, ORI found that Dr. Yibin Lin, former postdoctoral fellow, McGovern Medical School, UTHealth, engaged in research misconduct in research supported by PHS funds, specifically NIAID, NIH, grant R01 AI125216. VerDate Sep<11>2014 17:13 Feb 03, 2021 Jkt 253001 ORI found that Respondent engaged in research misconduct by knowingly and intentionally falsifying, fabricating, and plagiarizing data and text reported in the following published papers, which have been retracted, and manuscripts: Published Papers • Efficient Method for Genomic DNA Mutagenesis in E. coli. bioRxiv 2020. doi: https://doi.org/10.1101/ 2020.05.16.097097. • A simple and efficient method for in vitro site directed mutagenesis. bioRxiv 2020. doi: https://doi.org/ 10.1101/2020.05.16.100107. • A restriction-free method for gene reconstitution. bioRxiv 2020. doi: https://doi.org/10.1101/ 2020.05.20.107631. • Efficient Method for Protein Crystallization. bioRxiv 2020. doi: https://doi.org/10.1101/ 2020.05.24.113860. • Rice Tolerance to Drought is Complex Both Physiologically and Genetically. bioRxiv 2020. doi: https:// doi.org/10.1101/2020.08.19.258293. • ITS2 Pretrial Gene Identification Related to Seed and Flower Identification for Cyclea barbata. bioRxiv 2020. doi: https://doi.org/ 10.1101/2020.08.20.259804. Manuscripts Submitted to bioRxiv in 2020 and Not Published • Analysis of the Deduced Amino Acid Sequence of Lectin-like Protein. • Comprehensive proteomic characterization of ovarian tumors. • Insight into the membrane protein localization and antibiotic resistance by fluorescence microscopy. • Invariant States of the Algebra of Observables. • The Biochemical Analysis the Expression Levels of Pre-synaptic, Postsynaptic, Nuclear and Mitochondrial Markers. • The Overall Difference Analysis of Antioxidant of Isoflavone from Three Kinds of Soybean Stems. • The Overall Difference Analysis of Antioxidant of Isoflavone from Three Kinds of Tomato. Manuscript Rejected by bioRxiv and Resubmitted to medRxiv in 2020 • Invariant States of the Algebra of Observables. ORI finds that Respondent knowingly and intentionally falsified, fabricated, and plagiarized the whole content of six (6) papers and eight (8) manuscripts, falsely created fictitious author names and affiliations without listing himself as an author to disguise himself from being the offender, and submitted them PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 8203 for publication in bioRxiv and medRxiv, open access preprint repositories, by falsely assembling random paragraphs of text, tables, and figures from previous publications and manuscripts to improve his citation metrics. Dr. Lin entered into a Voluntary Exclusion Agreement (Agreement) and agreed to the following: (1) Because the Respondent also attempted to deceive the online publication sites bioRxiv and medRxiv by creating fictitious author names and affiliations without listing himself as an author, Respondent agreed to exclude himself voluntarily for a period of ten (10) years beginning on January 7, 2021, from any contracting or subcontracting with any agency of the United States Government and from eligibility for or involvement in nonprocurement programs of the United States Government referred to as ‘‘covered transactions’’ pursuant to HHS’ Implementation (2 CFR part 376) of OMB Guidelines to Agencies on Governmentwide Debarment and Suspension, 2 CFR part 180 (collectively the ‘‘Debarment Regulations’’); and (2) Respondent agreed to exclude himself voluntarily from serving in any advisory capacity to PHS including, but not limited to, service on any PHS advisory committee, board, and/or peer review committee, or as a consultant for a period of ten (10) years, beginning on January 7, 2021. Dated: January 29, 2021. Wanda K. Jones, Acting Director, Office of Research Integrity, Office of the Assistant Secretary for Health. [FR Doc. 2021–02273 Filed 2–3–21; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\04FEN1.SGM 04FEN1

Agencies

[Federal Register Volume 86, Number 22 (Thursday, February 4, 2021)]
[Notices]
[Pages 8202-8203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02272]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct; Correction

AGENCY: Office of the Secretary, HHS.

ACTION: Correction of notice.

-----------------------------------------------------------------------

SUMMARY: This document corrects errors that appeared in the notice 
published in the November 7, 2019, Federal Register entitled ``Findings 
of Research Misconduct.''

DATES: 
    Effective Date: February 4, 2021.
    Applicability Date: The correction notice is applicable for the 
Findings of Research Misconduct notice published on November 7, 2019.

FOR FURTHER INFORMATION CONTACT:  Ms. Karen Gorirossi or Dr. Alexander 
Runko at 240-453-8800.

SUPPLEMENTARY INFORMATION: 

I. Background

    In FR Doc. 2019-24291 of November 7, 2019 (84 FR 60097-60098), 
there were errors involving incorrect citations for published papers 
affecting six paragraphs on page 60098. The errors are identified and 
corrected in the Correction of Errors section below.

II. Correction of Errors

    In FR Doc. 2019-24291 of November 7, 2019 (84 FR 60097-60098), make 
the following corrections:
    1. On page 60098, first column, in FR Doc. 2019-24291, fifth 
paragraph, lines 1-2, change ``Am. J. Physiol. Lung Cell. Mol. Biol.'' 
to ``Am. J. Resp. Cell. Mol. Biol.'' and in lines 3-5, remove 
``(hereafter referred to as ``Am. J. Physiol. Lung Cell. Mol. Biol. 
2011b paper).''
    2. On page 60098, first column, in FR Doc. 2019-24291, twelfth 
paragraph, lines 1-2, change ``Am. J. Physiol. Lung Cell. Mol. Biol.'' 
to ``Am. J. Resp. Cell. Mol. Biol.''
    3. On page 60098, first column, in FR Doc. 2019-24291, sixteenth 
paragraph, lines 1-2, change ``J. Immunol. 2007;2179:4367-75'' to ``J. 
Immunol. 2007;179:4367-75.''
    4. On page 60098, second column, in FR Doc. 2019-24291, second 
paragraph,

[[Page 8203]]

lines 2-3, change ``Am. J. Physiol. Lung Cell. Mol. Biol.'' to ``Am. J. 
Resp. Cell. Mol. Biol.''
    5. On page 60098, second column, in FR Doc. 2019-24291, sixth 
paragraph, lines 1 and 3, change ``J. App. Physiol.'' to ``J. Appl. 
Physiol.''
    6. On page 60098, second column, in FR Doc. 2019-24291, twenty-
third paragraph, lines 1-2, change ``Am. J. Physiol. Lung Cell. Mol. 
Biol. 2011b paper'' to ``Am. J. Physiol. Lung Cell. Mol. Physiol. 
2011;301(3):L327-L333.''

    Dated: January 29, 2021.
Wanda K. Jones,
Acting Director, Office of Research Integrity.
[FR Doc. 2021-02272 Filed 2-3-21; 8:45 am]
BILLING CODE 4150-31-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.